E-DRUG: FDA online conference: Regulatory Best Practices for Global Access to Medicines, Including Anti-TB Medicines
----------------------------------------------------------------------------
Dear e-Drug,
In collaboration with the U.S. FDA, the Promoting the Quality of Medicines Plus (PQM+) program, which is funded by USAID, would like to invite you to a three-day conference on international best practices for regulatory review and approval of medical products, including Anti-TB Medicines. Speakers include experts from the U.S. FDA, WHO, USP and USAID. This free, online event is designed for National Medicines Regulatory Authorities (NMRAs) in low-and middle-income countries (LMICs) to gain a better understanding of:
* FDA drug approval pathways and application review, including for new and generic drugs, with an emphasis on TB medicines.
* Role of FDA in international regulatory harmonization.
* Collaboration between FDA, WHO, and NMRAs to support the drug approval process in LMICs.
* Role of USP and USAID's PQM+ program in supporting regulatory systems in LMICs.
* Other regulatory resources for NMRAs in LMICs.
Dates: August 16-18, 2022 from 8:30 a.m. - 12:30 p.m. EDT
Registration and Agenda:
Megan Meline
Senior Communications Manager
Promoting the Quality of Medicines Plus (PQM+) Program
U.S. Pharmacopeial Convention
12601 Twinbrook Parkway, Rockville, MD, 20852, USA
Megan Meline <megan.meline@USP.org>